Biotechnology Immunotherapies

Phase III Immunotherapy Trial for Migraine Shows Positive Results

An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month in a phase III trial. A new study of fremanezumab, an immunotherapy that counteracts one of the molecules released during migraine, was found successful in reducing the number of days that chronic […]

Uncategorized

Montefiore and Einstein Researchers Leverage Social Media to Uncover New Data on Migraine Sensory Experiences

A highly trafficked social media forum is yielding new findings on migraine symptoms, according to clinical researchers from the Montefiore Headache Center and Albert Einstein College of Medicine. A new report, “Special sensory experiences in migraine: a social media study,” reveals important disease epidemiology on migraine experiences like olfactory hallucinations, which may not be uncovered […]